Correspondence

Source: The International Journal of Tuberculosis and Lung Disease, Volume 10, Number 9, September 2006 , pp. 1063-1065(3)

Publisher: International Union Against Tuberculosis and Lung Disease

Buy & download fulltext article:

The full text is free.

View now:

PDF 45.9kb

Abstract:

6-month treatment for bone tuberculosis. Joke H. van Loenhout-Rooyackers, P. C. Jutte, and R. van Altena, GGD (Public Health Office), Nijmegen, The Netherlands

In reply. S. Ramachandran and I. J. Clifton, Department of Respiratory Medicine, Leeds General Infirmary, Leeds, United Kingdom; T. A. Collyns, Department of Microbiology, Leeds General Infirmary, Leeds, United Kingdom; J. P. Watson and S. B. Pearson, Department of Respiratory Medicine, Leeds General Infirmary, Leeds, United Kingdom

Refocus on the stability and quality of anti-tuberculosis formulations. Saranjit Singh, Hemant Bhutani, and Bhagwat Prasad, Department of Pharmaceutical Analysis, NIPER, SAS Nagar, India

In reply. Korngamon Rookkapan, Department of Pharmacy Administration, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla, Thailand

Document Type: Letter paper

Publication date: 2006-09-01

More about this publication?

The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.
Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website
Editorial Board
Information for Authors
Subscribe to this Title
ingentaconnect is not responsible for the content or availability of external websites